QTX-2101

· Quetzal Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QTX-2101, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia [Phase 3]

See pricing